Literature DB >> 8015862

Congenital infection with Toxoplasma gondii.

N G Guerina1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8015862     DOI： 10.3928/0090-4481-19940301-07

Source DB:  PubMed          Journal:  Pediatr Ann        ISSN： 0090-4481            Impact factor:   1.132


× No keyword cloud information.
  11 in total

1.  Lack of value of specific IgA detection in the postnatal diagnosis of congenital toxoplasmosis.

Authors:  A K Faure; H Fricker-Hidalgo; H Pelloux; C Bost-Bru; A Goullier-Fleuret; P Ambroise-Thomas
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Sero-epidemiology and risk factors for Toxoplasma gondii among pregnant women in Arab and African countries.

Authors:  Mohamed Alkhatim Alsammani
Journal:  J Parasit Dis       Date:  2014-09-20

3.  Strategy for diagnosis of congenital toxoplasmosis: evaluation of methods comparing mothers and newborns and standard methods for postnatal detection of immunoglobulin G, M, and A antibodies.

Authors:  J M Pinon; H Dumon; C Chemla; J Franck; E Petersen; M Lebech; J Zufferey; M H Bessieres; P Marty; R Holliman; J Johnson; V Luyasu; B Lecolier; E Guy; D H Joynson; A Decoster; G Enders; H Pelloux; E Candolfi
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

4.  Prospective study of congenital toxoplasmosis screening with use of IgG avidity and multiplex nested PCR methods.

Authors:  Hideto Yamada; Akira Nishikawa; Tomohiro Yamamoto; Yuka Mizue; Takashi Yamada; Mayumi Morizane; Shinya Tairaku; Jun Nishihira
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

5.  Evaluation of a new protocol for retrospective diagnosis of congenital toxoplasmosis by use of Guthrie cards.

Authors:  Antonella Marangoni; Maria Grazia Capretti; Morena De Angelis; Paola Nardini; Monica Compri; Claudio Foschi; Azzurra Orlandi; Concetta Marsico; Francesca Righetti; Giacomo Faldella; Roberto Cevenini
Journal:  J Clin Microbiol       Date:  2014-06-04       Impact factor: 5.948

6.  Population pharmacokinetics of pyrimethamine and sulfadoxine in children with congenital toxoplasmosis.

Authors:  T Trenque; N Simon; I Villena; C Chemla; C Quereux; B Leroux; R Jaussaud; G Rémy; D Dupouy; H Millart; J-M Pinon; S Urien
Journal:  Br J Clin Pharmacol       Date:  2004-06       Impact factor: 4.335

Review 7.  Disorders of the fetomaternal unit: hematologic manifestations in the fetus and neonate.

Authors:  L Vandy Black; Akhil Maheshwari
Journal:  Semin Perinatol       Date:  2009-02       Impact factor: 3.300

8.  An assessment of the human health impact of seven leading foodborne pathogens in the United States using disability adjusted life years.

Authors:  E Scallan; R M Hoekstra; B E Mahon; T F Jones; P M Griffin
Journal:  Epidemiol Infect       Date:  2015-01-30       Impact factor: 4.434

Review 9.  Macrophage migration inhibitory factor (MIF): a key player in protozoan infections.

Authors:  Juan de Dios Rosado; Miriam Rodriguez-Sosa
Journal:  Int J Biol Sci       Date:  2011-10-25       Impact factor: 6.580

10.  Cytomegalovirus, Toxoplasma gondii and Rubella Vertical Transmission Rates According to Mid-trimester Amniocentesis: A Retrospective Study.

Authors:  Chrysoula Margioula-Siarkou; Ioannis Kalogiannidis; Stamatios Petousis; Stella Prapa; Themistoklis Dagklis; Apostolos Mamopoulos; Nikos Prapas; David Rousso
Journal:  Int J Prev Med       Date:  2015-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.